Female Reproductive System Carcinoma — Trials

Female Reproductive System Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

1,480 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 457
Recruiting: 229
Ph III recruiting: 25
Growth YoY: +33.8%
Industry share: 26%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (201)

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07678047	Leveraging Project ECHO for Improved Cervical Cancer Screening in Ethiopia	enrolling by invitation	N/A	60	Albert Einstein College of MedicineOTHER	1	Jul 1, 2026	clinicaltrials
NCT07186530	Offering HPV Self-Collection in Novel Healthcare Settings to Improve Uptake of Cervical Cancer Screening	enrolling by invitation	N/A	500	Mayo ClinicOTHER	1	Jun 9, 2026	clinicaltrials